Literature DB >> 27726468

TRPV1 Antagonist Suppresses Allergic Conjunctivitis in a Murine Model.

Ji Young Kwon1, Hyun Soo Lee1,2, Choun-Ki Joo1,2.   

Abstract

PURPOSE: To determine the immunologic functions of TRPA1 or TRPV1 in allergic conjunctivitis (AC).
METHODS: Mice were sensitized with ovalbumin (OVA), after which TRPA1 antagonist or TRPV1 antagonist was administered before topical OVA challenge. Expression of TRPV1 or TRPA1 in AC was examined by western blotting and multicolor immunofluorescence. Clinical signs, OVA-specific IgE, infiltration of inflammatory cells into conjunctivae (CJs), and Th2 cytokine in draining lymph nodes (LNs) were evaluated by microscopy, flow cytometry, and ELISA.
RESULTS: TRPV1 expression was increased in CJs and LNs from AC mice, but TRPA1 expression was only increased in LNs. TRPV1 antagonist but not TRPA1 antagonist attenuated the clinical signs of AC and OVA-specific IgE in sera. TRPV1 antagonist furthermore inhibited the infiltration of inflammatory cells into CJ and the production of Th2 cytokines in LNs.
CONCLUSION: TRPV1 antagonist but not TRPA1 antagonist may ameliorate AC by suppressing the Th2 response in LNs.

Entities:  

Keywords:  Allergic conjunctivitis; TRPA1; TRPV1; Th2 cytokines; inflammatory cells

Mesh:

Substances:

Year:  2016        PMID: 27726468     DOI: 10.1080/09273948.2016.1231330

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

Review 1.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

2.  Distribution of serum specific IgE in children with allergic conjunctivitis and analysis of its concomitant allergic diseases.

Authors:  Wenjun Wang; Xiumei Du; Lu Ye; Xiaoli Wang; Guoyun Zhang
Journal:  Transl Pediatr       Date:  2020-10

Review 3.  Therapeutic Targets in Allergic Conjunctivitis.

Authors:  Bisant A Labib; DeGaulle I Chigbu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-28

Review 4.  Allergic conjunctivitis in Asia.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2017-04-12

Review 5.  Advances in TRP channel drug discovery: from target validation to clinical studies.

Authors:  Ari-Pekka Koivisto; Maria G Belvisi; Rachelle Gaudet; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2021-09-15       Impact factor: 112.288

Review 6.  TRPA1 Expression and Pathophysiology in Immune Cells.

Authors:  Robbe Naert; Alejandro López-Requena; Karel Talavera
Journal:  Int J Mol Sci       Date:  2021-10-24       Impact factor: 5.923

7.  Involvement of transient receptor potential channels in ocular diseases: a narrative review.

Authors:  Tian-Jing Yang; Yang Yu; Jing-Yi Yang; Jin-Jing Li; Jun-Ya Zhu; João Alexandre Cardoso Vieira; Qin Jiang
Journal:  Ann Transl Med       Date:  2022-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.